{
    "root": "767a4ad4-9fab-4348-9ad4-8054620aaa2d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cefdinir",
    "value": "20250422",
    "ingredients": [
        {
            "name": "CEFDINIR MONOHYDRATE",
            "code": "6E7SN358SE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3485"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30769"
        },
        {
            "name": "SILICA",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "GUAR GUM",
            "code": "E89I1637KE",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13446"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_113455"
        },
        {
            "name": "ANHYDROUS TRISODIUM CITRATE",
            "code": "RS7A450LGA"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_189560"
        }
    ],
    "indications": {
        "text": "reduce development drug-resistant bacteria maintain effectiveness cefdinir oral suspension , usp antibacterial drugs , cefdinir oral suspension , usp used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy . cefdinir oral suspension , usp indicated treatment patients mild moderate infections caused susceptible strains designated microorganisms conditions listed .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "( usage indicated pathogens . )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "product : 50090-4258 ndc : 50090-4258-0 60 ml bottle",
    "adverseReactions": "cefdinir oral suspension contraindicated patients known allergy cephalosporin class antibiotics .",
    "indications_original": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefdinir for oral suspension, USP and other antibacterial drugs, cefdinir for oral suspension, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.\n                  Cefdinir for oral suspension, USP is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.",
    "contraindications_original": "(See \n                        INDICATIONS AND USAGE\n                     for Indicated Pathogens.)",
    "warningsAndPrecautions_original": "Product:    50090-4258\n                  NDC:    50090-4258-0   60 mL in a BOTTLE",
    "adverseReactions_original": "Cefdinir for oral suspension is contraindicated in patients with known allergy to the cephalosporin class of antibiotics.",
    "drug": [
        {
            "name": "Cefdinir",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3485"
        }
    ]
}